# FDA Inspection 1300262 - William C. Nabours, M.D. - January 16, 2026

Source: https://www.keypedia.com/records/fda_inspections/william-c-nabours-md/0f024f0c-9831-4034-9b54-d35412dc74a0
Source feed: FDA_Inspections

> FDA Inspection 1300262 for William C. Nabours, M.D. on January 16, 2026. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300262
- Company Name: William C. Nabours, M.D.
- Inspection Date: 2026-01-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Office Name: New Orleans District Office

## Related Documents

- [FDA Inspection 1300262 - 2026-01-16](https://www.keypedia.com/records/fda_inspections/william-c-nabours-md/35fb098a-c8e4-4a5f-bf41-076b7d1c3a40)

Company: https://www.keypedia.com/companies/william-c-nabours-md/72c17a7d-1216-45f8-aff6-5f7fc615f98d

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea